Why does this Omega-3 primarily contain DHA and not EPA?Updated a month ago

DHA is central to brain structure and function: 

Docosahexaenoic acid (DHA) makes up about 90% of the brain’s omega-3 content and roughly 10-15% of its total fatty acids. It is built directly into neuronal membranes, supporting fluidity, signaling, and neuroplasticity, which are key for cognitive development and healthy aging.

EPA’s benefits are less consistent, even for heart health:

Eicosapentaenoic acid (EPA) is often cited for cardiovascular support and anti-inflammatory action, yet large clinical trials and meta-analyses show mixed results. While some high-dose purified EPA interventions in high-risk patients improve certain outcomes, many standard-dose mixed EPA/DHA studies report neutral effects on cardiovascular events and no clear cognitive advantage.

Formulation that matches the evidence:

DHA has the strongest and most consistent research basis for brain health, while EPA’s benefits (including cardiovascular) remain inconsistent at typical supplement doses. Because of this, we prioritize DHA in our algal omega-3 formulation.